GlassScriptPhysician profile
Yvonne Hsia
NPI 1962025197
$1,430.13
in general payments reported to CMS, 2019-2025
14 companies · $22.86 in 2025
The $22.86 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.62 · 2022: $638 · 2023: $712 · 2024: $15.09 · 2025: $22.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.09 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $393.36 | 2022-2023 | Rybelsus, Ozempic |
| Mylan Specialty L.P. | $310.96 | 2021-2023 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $200.76 | 2022-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $146.08 | 2022-2023 | |
| Glaxosmithkline, LLC. | $104.05 | 2022-2024 | Bexsero, Pediarix, Shingrix |
| Abbvie INC. | $85.37 | 2022-2023 | |
| Pfizer INC. | $54.17 | 2022-2023 | |
| Lilly USA, LLC | $26.95 | 2023 | Trulicity, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.56 | 2022 | |
| Edwards Lifesciences Corporation | $22.86 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Xeris Pharmaceuticals, INC. | $20.11 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.79 | 2023 | Edarbi |
| Merck Sharp & Dohme LLC | $14.27 | 2022 | |
| Cranial Technologies, INC | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvonne Hsia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.